Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009
Fierce Biotech
Saturday, October 31, 2009 - 12:03pm
tags:
Sanofi
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia
PR-USA.net
Saturday, October 31, 2009 - 12:02pm
tags:
Astellas, Theravance, pneumonia
AcelRx Announces Successful Completion Of End-of-Phase 2 Meeting On ARX-01, Sufentanil NanoTab PCA System For Post-Operative Pain Management
Medical News Today
Saturday, October 31, 2009 - 11:59am
tags:
Sufentanil NanoTab PCA System, AcelRx, pain management
Alexion Pharmaceuticals Inc. Leads Tech Top 40 Listings (in Connecticut)
Hartford Courant
Saturday, October 31, 2009 - 11:56am
tags:
Alexion
US FDA seeks more data from Transcept's insomnia drug Intermezzo
Pharmbiz
Saturday, October 31, 2009 - 11:53am
tags:
Transcept, Intermezzo
SemBioSys enters in non-dilutive financing plan of arrangement
CNW Telbec
Saturday, October 31, 2009 - 11:49am
tags:
SemBioSys
Valeant to Acquire Polish Products
PR NewsWire
Saturday, October 31, 2009 - 11:44am
tags:
Valeant Pharmaceuticals
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
PR NewsWire
Saturday, October 31, 2009 - 11:39am
tags:
Eisai, Eribulin, breast cancer
Gilead: Transforming AIDS
Forbes
Saturday, October 31, 2009 - 10:55am
tags:
Gilead Sciences, AIDS
Abbott suing Impax Labs over generic TriCor
Yahoo/AP
Saturday, October 31, 2009 - 10:54am
tags:
Abbott Laboratories, Impax, TriCor
Sanofi CEO: Animal-Biz Combo With Merck ‘More Likely Than Not’
Wall St. Journal
Saturday, October 31, 2009 - 10:53am
tags:
Merck, Sanofi
Shrugging Off the Side Effects
Motley Fool
Saturday, October 31, 2009 - 10:52am
tags:
Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
Yahoo/PR NewsWire
Saturday, October 31, 2009 - 10:50am
tags:
biotech
It's Not As Frightening As It First Appears (Mylan)
Motley Fool
Saturday, October 31, 2009 - 10:49am
tags:
Mylan
Of One-Time Gains and Pipelines
Motley Fool
Saturday, October 31, 2009 - 10:48am
tags:
Amgen Drug May Increase Stroke Risk in Some: Study
CNBC
Saturday, October 31, 2009 - 10:46am
tags:
Amgen, Aranesp
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
Yahoo/PR NewsWire
Saturday, October 31, 2009 - 10:45am
tags:
Byetta, Amylin, Eli Lilly, type 2 diabetes
GTx’s stock slides before conference call
bizjournals.com
Saturday, October 31, 2009 - 10:43am
tags:
GTx, prostate cancer, Acapodene
15 states sue Amgen alleging kickback scheme
Yahoo/AP
Saturday, October 31, 2009 - 10:42am
tags:
Amgen
Warner Chilcott closes $3.1 billion buyout of Procter & Gamble's drug unit
Yahoo/AP
Friday, October 30, 2009 - 10:59am
tags:
Proctor & Gamble, M&A, Warner Chilcott

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.